On June 10, 2020, the greater Seattle Coronavirus Assessment Network (SCAN) resumed testing of home-based, self-collected samples for coronavirus disease 2019 (COVID-19). SCAN launched in March 2020, but had been paused since May 12, 2020 when the U.S. Food and Drug Administration (FDA) informed SCAN that its home testing program had to take place as a study approved by an Institutional Review Board (IRB), or under an Emergency Use Authorization (EUA). The FDA has previously issued guidance on home-testing programs. SCAN is resuming operations as a research study with IRB approval and oversight from the . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!